Login / Signup

Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis.

Ben-Gang ZhouLing-Xiao ChenBo LiLin-Yan WanYao-Wei Ai
Published in: Helicobacter (2019)
Our meta-analysis shows that S boulardii supplementation on standard eradication therapy significantly increased H pylori eradication rates and reduced the incidence of total side effects and some gastrointestinal adverse effects during eradication therapy.
Keyphrases
  • helicobacter pylori infection
  • helicobacter pylori
  • systematic review
  • early stage
  • clinical trial
  • study protocol
  • meta analyses
  • phase iii
  • randomized controlled trial
  • phase ii
  • cell therapy
  • open label